enVVeno Medical

IN THE PRESS

Press Releases

enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium

November 20, 2024

·

7 min read

Press Releases

enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval

November 20, 2024

·

4 min read

Press Releases

enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year

November 1, 2024

·

5 min read

Press Releases

enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R)

October 28, 2024

·

5 min read

Press Releases

enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing

September 3, 2024

·

6 min read

Press Releases

enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)

August 14, 2024

·

6 min read

Press Releases

enVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update

August 1, 2024

·

6 min read

Biotech Beach

Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium

April 24, 2024

·

7 min read

Biotech Beach

New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024

April 16, 2024

·

6 min read

Biotech Beach

Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting

March 6, 2024

·

7 min read

JOBS